{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:31:55Z","timestamp":1793644315149,"version":"4.5.1"},"reference-count":62,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T00:00:00Z","timestamp":1698364800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.heliyon.2023.e21789","type":"journal-article","created":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T21:05:42Z","timestamp":1698786342000},"page":"e21789","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Cerium oxide nanoparticles modulating the Parkinson's disease conditions: From the alpha synuclein structural point of view and antioxidant properties of cerium oxide nanoparticles"],"prefix":"10.1016","volume":"10","author":[{"given":"Xiaomei","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichao","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.heliyon.2023.e21789_bib1","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000520726","article-title":"Prevalence of Parkinson's disease in adults aged 65 years and older in China: a multicenter population-based survey","volume":"56","author":"Song","year":"2022","journal-title":"Neuroepidemiology"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e21789_bib2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41531-022-00280-4","article-title":"A nationwide study of the incidence, prevalence and mortality of Parkinson's disease in the Norwegian population","volume":"8","author":"Brakedal","year":"2022","journal-title":"npj Parkinson's Disease"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e21789_bib3","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/01913123.2021.2015499","article-title":"Testing efficacy of the nicotine protection of the substantia nigra pars compacta in a rat Parkinson disease model. Ultrastructure study","volume":"46","author":"Elgayar","year":"2022","journal-title":"Ultrastruct. Pathol."},{"key":"10.1016\/j.heliyon.2023.e21789_bib4","doi-asserted-by":"crossref","DOI":"10.1021\/acschemneuro.2c00679","article-title":"Neuroprotective effects of lactoferrin in alzheimer's and Parkinson's diseases: a narrative review","author":"Yong","year":"2023","journal-title":"ACS Chem. Neurosci."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e21789_bib5","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/10738584211011979","article-title":"Non-motor symptoms of Parkinson's disease: the neurobiology of early psychiatric and cognitive dysfunction","volume":"29","author":"Hussein","year":"2023","journal-title":"Neuroscientist"},{"key":"10.1016\/j.heliyon.2023.e21789_bib6","doi-asserted-by":"crossref","DOI":"10.1093\/cercor\/bhac503","article-title":"Individual-level functional connectomes predict the motor symptoms of Parkinson's disease","author":"Shi","year":"2023","journal-title":"Cerebr. Cortex"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e21789_bib7","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10367","article-title":"Alzheimer's and Parkinson's disease therapies in the clinic","volume":"8","author":"Chopade","year":"2023","journal-title":"Bioengineering & Translational Medicine"},{"key":"10.1016\/j.heliyon.2023.e21789_bib8","series-title":"A Comparison between Early Presentation of Dementia with Lewy Bodies, Alzheimer's Disease and Parkinson's Disease: Evidence from Routine Primary Care and UK Biobank Data","first-page":"2023","author":"Nedelec","year":"2023"},{"key":"10.1016\/j.heliyon.2023.e21789_bib9","first-page":"1","article-title":"Dietary polyphenols: regulate the advanced glycation end products-RAGE axis and the microbiota-gut-brain axis to prevent neurodegenerative diseases","author":"Li","year":"2022","journal-title":"Crit. Rev. Food Sci. Nutr."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e21789_bib10","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s10038-022-01058-5","article-title":"Molecular genetics of Parkinson's disease: contributions and global trends","volume":"68","author":"Funayama","year":"2023","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.heliyon.2023.e21789_bib11","doi-asserted-by":"crossref","DOI":"10.1111\/jocn.16636","article-title":"Perspectives of people with Parkinson's disease and family carers about disease management in community settings: a cross\u2010country qualitative study","author":"Navarta\u2010S\u00e1nchez","year":"2023","journal-title":"J. Clin. Nurs."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e21789_bib12","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/neup.12812","article-title":"Neuropathology of \u03b1\u2010synuclein in Parkinson's disease","volume":"42","author":"Choong","year":"2022","journal-title":"Neuropathology"},{"issue":"6","key":"10.1016\/j.heliyon.2023.e21789_bib13","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2113489119","article-title":"Different \u03b1-synuclein prion strains cause dementia with Lewy bodies and multiple system atrophy","volume":"119","author":"Ayers","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e21789_bib14","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00401-022-02453-0","article-title":"\u03b1-Synuclein molecular behavior and nigral proteomic profiling distinguish subtypes of Lewy body disorders","volume":"144","author":"Martinez-Valbuena","year":"2022","journal-title":"Acta Neuropathol."},{"issue":"12","key":"10.1016\/j.heliyon.2023.e21789_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102565","article-title":"Anionic lipid vesicles have differential effects on the aggregation of early onset-associated \u03b1-synuclein missense mutants","volume":"298","author":"Watt","year":"2022","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.heliyon.2023.e21789_bib16","series-title":"Alpha Synuclein Specific T Lymphocytes Promote Neurodegeneration in the A53T-\u03b1-Synuclein Parkinson's Disease Mouse Model","author":"Karikari","year":"2022"},{"key":"10.1016\/j.heliyon.2023.e21789_bib17","article-title":"Targeting G protein-coupled receptors in the treatment of Parkinson's disease","author":"Jones-Tabah","year":"2022","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.heliyon.2023.e21789_bib18","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jconrel.2018.08.035","article-title":"Dopamine-loaded blood exosomes targeted to brain for better treatment of Parkinson's disease","volume":"287","author":"Qu","year":"2018","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.heliyon.2023.e21789_bib19","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3389\/fnagi.2017.00176","article-title":"Targeting microglial activation states as a therapeutic avenue in Parkinson's disease","volume":"9","author":"Subramaniam","year":"2017","journal-title":"Front. Aging Neurosci."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e21789_bib20","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.nurt.2008.02.003","article-title":"Treatment of Parkinson's disease with trophic factors","volume":"5","author":"Peterson","year":"2008","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.heliyon.2023.e21789_bib21","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s40265-020-01310-2","article-title":"Therapeutic strategies to treat or prevent off episodes in adults with Parkinson's disease","volume":"80","author":"Vijiaratnam","year":"2020","journal-title":"Drugs"},{"key":"10.1016\/j.heliyon.2023.e21789_bib22","series-title":"Diagnosis and Management of Pain in Parkinson's Disease: an Original Approach","author":"Mylius","year":"2021"},{"key":"10.1016\/j.heliyon.2023.e21789_bib23","series-title":"Neurobiology of Depression in Parkinson's Disease: Insights into Epidemiology, Molecular Mechanisms and Treatment Strategies","author":"Ahmad","year":"2023"},{"key":"10.1016\/j.heliyon.2023.e21789_bib24","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jconrel.2018.12.036","article-title":"Micro-and nanotechnology approaches to improve Parkinson's disease therapy","volume":"295","author":"Torres-Ortega","year":"2019","journal-title":"J. Contr. Release"},{"issue":"9","key":"10.1016\/j.heliyon.2023.e21789_bib25","doi-asserted-by":"crossref","first-page":"775","DOI":"10.3109\/1061186X.2015.1020809","article-title":"Nanotechnology-mediated nose to brain drug delivery for Parkinson's disease: a mini review","volume":"23","author":"Kulkarni","year":"2015","journal-title":"J. Drug Target."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e21789_bib26","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1080\/10717544.2017.1359862","article-title":"Nanotechnology-based drug delivery of ropinirole for Parkinson's disease","volume":"24","author":"Barcia","year":"2017","journal-title":"Drug Deliv."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e21789_bib27","doi-asserted-by":"crossref","first-page":"155","DOI":"10.5599\/admet.3.3.189","article-title":"Nanotechnology platforms in Parkinson's disease","volume":"3","author":"Adhikary","year":"2015","journal-title":"ADMET and DMPK"},{"key":"10.1016\/j.heliyon.2023.e21789_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2023.167992","article-title":"Common mechanisms underlying \u03b1-synuclein-induced mitochondrial dysfunction in Parkinson's disease","author":"Sohrabi","year":"2023","journal-title":"J. Mol. Biol."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e21789_bib29","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/mds.29287","article-title":"Cerebrospinal fluid biomarkers of synaptic dysfunction are altered in Parkinson's disease and related disorders","volume":"38","author":"Nilsson","year":"2023","journal-title":"Mov. Disord."},{"key":"10.1016\/j.heliyon.2023.e21789_bib30","first-page":"1","article-title":"Alpha-synuclein in Parkinson's disease: a villain or tragic hero? A critical view of the formation of \u03b1-synuclein aggregates induced by dopamine metabolites and viral infection","author":"Carmo-Gon\u00e7alves","year":"2023","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.heliyon.2023.e21789_bib31","first-page":"1","article-title":"Restoration of adult neurogenesis by intranasal administration of gangliosides GD3 and GM1 in the olfactory bulb of A53T alpha-synuclein-expressing Parkinson\u2019s-disease model mice","author":"Fuchigami","year":"2023","journal-title":"Mol. Neurobiol."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e21789_bib32","first-page":"773","article-title":"The GBA variant E326K is associated with alpha-synuclein aggregation and lipid droplet accumulation in human cell lines","volume":"32","author":"Smith","year":"2023","journal-title":"Hum. Mol. Genet."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e21789_bib33","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.3390\/ijms24054391","article-title":"The role of alpha-synuclein deposits in Parkinson's disease: a focus on the human retina","volume":"24","author":"Di Pippo","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e21789_bib34","first-page":"287","article-title":"Nanotechnology driven approaches for the management of Parkinson's disease: current status and future perspectives","volume":"22","author":"Sharma","year":"2021","journal-title":"Curr. Drug Metabol."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e21789_bib35","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.5958\/0974-360X.2020.00354.6","article-title":"Nanotechnology in Parkinson's disease-A review","volume":"13","author":"Acharya","year":"2020","journal-title":"Res. J. Pharm. Technol."},{"key":"10.1016\/j.heliyon.2023.e21789_bib36","series-title":"AIP Conference Proceedings","article-title":"Optical properties of cerium oxide (CeO2) nanoparticles synthesized by hydroxide mediated method","author":"Ali","year":"2018"},{"key":"10.1016\/j.heliyon.2023.e21789_bib37","first-page":"3","volume":"6","author":"Reshma","year":"2017","journal-title":"Cerium Oxide Nanoparticles: Synthesis, Characterization and Study of Antimicrobial Activity. J Nanomater Mol Nanotechnol"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e21789_bib38","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3390\/nanomanufacturing1030013","article-title":"Cerium oxide nanoparticles: synthesis and characterization for biosafe applications","volume":"1","author":"Tumkur","year":"2021","journal-title":"Nanomanufacturing"},{"issue":"6","key":"10.1016\/j.heliyon.2023.e21789_bib39","doi-asserted-by":"crossref","DOI":"10.5530\/pj.2016.6.10","article-title":"Antioxidant and hypoglycemic activities of clausena anisata (Willd.) Hook F. ex benth. root mediated synthesized silver nanoparticles","volume":"8","author":"Yakoob","year":"2016","journal-title":"Phcog. J."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e21789_bib40","doi-asserted-by":"crossref","first-page":"4514","DOI":"10.1038\/s41598-023-31498-8","article-title":"Antioxidant and hypoglycemic potential of phytogenic cerium oxide nanoparticles","volume":"13","author":"Khan","year":"2023","journal-title":"Sci. Rep."},{"issue":"50","key":"10.1016\/j.heliyon.2023.e21789_bib41","doi-asserted-by":"crossref","first-page":"13394","DOI":"10.1021\/acs.langmuir.6b02935","article-title":"Curcumin-loaded amine-functionalized mesoporous silica nanoparticles inhibit \u03b1-synuclein fibrillation and reduce its cytotoxicity-associated effects","volume":"32","author":"Taebnia","year":"2016","journal-title":"Langmuir"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e21789_bib42","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ymeth.2004.03.012","article-title":"Techniques to study amyloid fibril formation in vitro","volume":"34","author":"Nilsson","year":"2004","journal-title":"Methods"},{"key":"10.1016\/j.heliyon.2023.e21789_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.123766","article-title":"Fabrication and characterization of Persian gum-based hydrogel loaded with gentamicin-loaded natural zeolite: an in vitro and in silico study","volume":"235","author":"Haghbin","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.heliyon.2023.e21789_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.mtcomm.2023.105915","article-title":"Exploring ZnO\/montmorillonite photocatalysts for the removal of hazardous RhB dye: a combined study using molecular dynamics simulations and experiments","author":"Haounati","year":"2023","journal-title":"Mater. Today Commun."},{"issue":"36","key":"10.1016\/j.heliyon.2023.e21789_bib45","doi-asserted-by":"crossref","first-page":"55131","DOI":"10.1007\/s11356-022-19657-2","article-title":"Theoretical and experimental study of the photodegradation of methyl orange in the presence of different morphologies of Au-ZnO using Monte Carlo dynamic simulation","volume":"29","author":"Fahimirad","year":"2022","journal-title":"Environ. Sci. Pollut. Control Ser."},{"key":"10.1016\/j.heliyon.2023.e21789_bib46","unstructured":"Dorairaj, D.P., et al., Anti\u2010proliferative potential of copper (I) acylthiourea complexes with triphenylphosphine against breast cancer cells. Appl. Organomet. Chem.: p e7087.."},{"key":"10.1016\/j.heliyon.2023.e21789_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcab.2023.102612","article-title":"Experimental and theoretical evaluation of biological properties of a phosphoramide functionalized graphene oxide","author":"Gholivand","year":"2023","journal-title":"Biocatal. Agric. Biotechnol."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e21789_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0122989","article-title":"Dielectrical properties of CeO2 nanoparticles at different temperatures","volume":"10","author":"Zamiri","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e21789_bib49","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.matchemphys.2008.12.031","article-title":"Synthesis, structural and optical properties of CeO2 nanoparticles synthesized by a simple polyvinyl pyrrolidone (PVP) solution route","volume":"115","author":"Phoka","year":"2009","journal-title":"Mater. Chem. Phys."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e21789_bib50","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.ceramint.2004.09.006","article-title":"Synthesis of nanocrystalline cerium oxide particles by the precipitation method","volume":"31","author":"Chen","year":"2005","journal-title":"Ceram. Int."},{"key":"10.1016\/j.heliyon.2023.e21789_bib51","series-title":"IOP Conference Series: Materials Science and Engineering","article-title":"Antioxidant activity and dose enhancement factor of CeO2 nanoparticles synthesized by precipitation method","author":"Nurhasanah","year":"2018"},{"issue":"1\u20132","key":"10.1016\/j.heliyon.2023.e21789_bib52","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jallcom.2009.12.053","article-title":"Synthesis, characterization and photoluminescence of CeO2 nanoparticles by a facile method at room temperature","volume":"493","author":"Wang","year":"2010","journal-title":"J. Alloys Compd."},{"issue":"25","key":"10.1016\/j.heliyon.2023.e21789_bib53","doi-asserted-by":"crossref","first-page":"5489","DOI":"10.1021\/cm048583p","article-title":"Combustion synthesis and characterization of nanocrystalline CeO2-based powders","volume":"16","author":"Mokkelbost","year":"2004","journal-title":"Chem. Mater."},{"key":"10.1016\/j.heliyon.2023.e21789_bib54","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s10971-006-7803-2","article-title":"Synthesis and acid functionalization of cerium oxide nanoparticles","volume":"39","author":"Pautrot-d\u2019Alen\u00e7on","year":"2006","journal-title":"J. Sol. Gel Sci. Technol."},{"key":"10.1016\/j.heliyon.2023.e21789_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2021.118085","article-title":"Molecular dynamics and quantum simulation of different cationic dyes removal from contaminated water using UiO-66 (Zr)-(COOH) 2 metal\u2013organic framework","volume":"349","author":"Feng","year":"2022","journal-title":"J. Mol. Liq."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e21789_bib56","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0014-2999(98)00393-8","article-title":"Effect of trihexyphenidyl, a non-selective antimuscarinic drug, on decarboxylation of L-dopa in hemi-Parkinson rats","volume":"353","author":"Izurieta-S\u00e1nchez","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.heliyon.2023.e21789_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2020.107308","article-title":"In silico drug repositioning of FDA-approved drugs to predict new inhibitors for alpha-synuclein aggregation","volume":"88","author":"Jafaripour","year":"2020","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.heliyon.2023.e21789_bib58","article-title":"Liposomal formulation of new arsenic schiff base complex as drug delivery agent in the treatment of acute promyelocytic leukemia and quantum chemical and docking calculations","volume":"75","author":"Iraji","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"13","key":"10.1016\/j.heliyon.2023.e21789_bib59","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1080\/00958972.2019.1656334","article-title":"Synthesis, structure, computational modeling and biological activity of two new Casiope\u00ednas\u00ae complexes and their nanoparticles","volume":"72","author":"Malekshah","year":"2019","journal-title":"J. Coord. Chem."},{"key":"10.1016\/j.heliyon.2023.e21789_bib60","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.molstruc.2017.08.079","article-title":"Crystal structure, molecular docking, and biological activity of the zinc complexes with 2-thenoyltrifluoroacetone and N-donor heterocyclic ligands","volume":"1150","author":"Malekshah","year":"2017","journal-title":"J. Mol. Struct."},{"issue":"21","key":"10.1016\/j.heliyon.2023.e21789_bib61","doi-asserted-by":"crossref","first-page":"7231","DOI":"10.1021\/acs.langmuir.2c03259","article-title":"Naringenin-functionalized gold nanoparticles and their role in \u03b1-synuclein stabilization","volume":"39","author":"Maity","year":"2023","journal-title":"Langmuir"},{"issue":"4","key":"10.1016\/j.heliyon.2023.e21789_bib62","doi-asserted-by":"crossref","first-page":"e3374","DOI":"10.1002\/psc.3374","article-title":"Tryptophan\u2010cardanol fluorescent nanoparticles inhibit \u03b1\u2010synuclein aggregation and disrupt amyloid fibrils","volume":"28","author":"Sunny","year":"2022","journal-title":"J. Pept. Sci."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023089971?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023089971?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:22:05Z","timestamp":1790655725000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844023089971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S2405844023089971"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e21789","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cerium oxide nanoparticles modulating the Parkinson's disease conditions: From the alpha synuclein structural point of view and antioxidant properties of cerium oxide nanoparticles","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e21789","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e21789"}}